Menu Content/Inhalt
Search  

PRESS RELEASES


   Order     Display # 
Date Item Title
21-Feb-2008 Debiopharm signs Canadian Partner for Sanvar®
22-Oct-2006 Debiopharm signs international license agreements for Sanvar®
04-Sep-2006 Debiopharm and Salix pharmaceuticals sign license agreement for Sanvar®
23-Jul-2006 Debiopharm applies for first europe marketing authorisation for Sanvar® in France
31-May-2006 The Debiopharm Group to initiate confirmatory phase III trial for Sanvar® in esophageal variceal bleeding
03-Jan-2005 H3 Pharma receives approvable letter from FDA for Sanvar® for esophageal variceal bleeding
23-Aug-2004 Mexico becomes first country to approve H3 Pharma´s Sanvar® for esophageal variecal bleeding and four other indications
01-Mar-2004 H3 Pharma Inc. Submits new drug application to FDA for Sanvar® IR
02-Dec-2003 H3 Pharma files Mexican registration submission for Sanvar IR in Esophageal Variceal Bleeding
23-Jul-2003 H3 Pharma Inc. announces important step in bringing SANVAR® (vapreotide) to U.S. market
 
< Prev 1 2 Next >
Results 1 - 10 of 12